57 related articles for article (PubMed ID: 20871428)
1. Long-term follow-up of a previously reported case of cerebellar aspergillosis with the implication of the potential therapeutic effect of intracavitary amphotericin B application.
Albayrak BS; Sirin S; Arpaci F; Erdogan E
Neurosurgery; 2010 Nov; 67(5):E1469-70. PubMed ID: 20871428
[No Abstract] [Full Text] [Related]
2. [Drug treatment of invasive aspergillosis of the paranasal sinuses].
Streppel M; Stennert E; Lackner KJ; Eckel HE; Arnold G
Laryngorhinootologie; 1997 Jan; 76(1):19-22. PubMed ID: 9156503
[TBL] [Abstract][Full Text] [Related]
3. Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?
Mihu CN; Kassis C; Ramos ER; Jiang Y; Hachem RY; Raad II
Cancer; 2010 Nov; 116(22):5290-6. PubMed ID: 20665889
[TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
Cordonnier C; Bresnik M; Ebrahimi R
Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
[TBL] [Abstract][Full Text] [Related]
5. Invasive cerebral aspergillosis in a patient with aplastic anemia. Response to liposomal amphotericin and surgery.
Rodríguez DL; López CA; Cobos EB; Blanco AJ; Fernández AF; Araujo LF
Haematologica; 1999 Aug; 84(8):758-9. PubMed ID: 10457420
[No Abstract] [Full Text] [Related]
6. [Percutaneous intracavitary treatment of pulmonary aspergilloma-clinical efficacy and prognosis].
Furuse F; Nakanishi Y; Kotoh H; Inoue H; Yatsunami J; Ikeda T; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jun; 32(6):538-43. PubMed ID: 8089940
[TBL] [Abstract][Full Text] [Related]
7. Intracavitary amphotericin B in the treatment of intracranial aspergillosis.
Kural C; Ozer MI; Ezgu MC; Mehtiyev R; Yasar S; Kutlay AM; Daneyemez MK; Onguru O; Erdogan E; Izci Y
J Clin Neurosci; 2018 May; 51():75-79. PubMed ID: 29506772
[TBL] [Abstract][Full Text] [Related]
8. [Palliative percutaneous treatment under ultrasonographic control of inoperable pulmonary aspergilloma: Galenic analysis].
Meges B; Segonds M; Garo A; Ane M; Giron J; Carles P
Rev Mal Respir; 1996 Dec; 13(6):614-5. PubMed ID: 9036512
[No Abstract] [Full Text] [Related]
9. Combination antifungal therapy for invasive aspergillosis: can it replace high-risk surgery at the skull base?
Panda NK; Saravanan K; Chakrabarti A
Am J Otolaryngol; 2008; 29(1):24-30. PubMed ID: 18061828
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of intracavitary amphotericin B in the treatment of aspergilloma associated with the acquired immunodeficiency syndrome].
Pintado V; Montilla P; Casado JL; Guerrero A
Med Clin (Barc); 1994 Sep; 103(7):279. PubMed ID: 7934299
[No Abstract] [Full Text] [Related]
11. Bilateral pulmonary aspergilloma in ankylosing spondylitis treated with transthoracic intracavitary instillations of antifungal agents.
Stiksa G; Eklundh G; Riebe I; Simonsson BG
Scand J Respir Dis; 1976; 57(4):163-70. PubMed ID: 790560
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.
Kirkpatrick WR; Vallor AC; McAtee RK; Ryder NS; Fothergill AW; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2005 Nov; 49(11):4751-3. PubMed ID: 16251321
[TBL] [Abstract][Full Text] [Related]
13. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191.
Graybill JR; Kaster SR
Am Rev Respir Dis; 1984 Feb; 129(2):292-5. PubMed ID: 6364905
[TBL] [Abstract][Full Text] [Related]
14. [Medical therapy of pleuro-pulmonary aspergillosis].
Guérin JC; Woehrle R; Kalb JC
J Med Lyon; 1972 May; 53(228):621-2 passim. PubMed ID: 4538887
[No Abstract] [Full Text] [Related]
15. Cerebellar aspergilloma.
Björkholm B; Elgefors B
Scand J Infect Dis; 1986; 18(4):375-8. PubMed ID: 3764353
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
Ho KM; Duff O; Chambers D; Murray R
Transpl Infect Dis; 2008 Jun; 10(3):168-76. PubMed ID: 18194368
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole versus amphotericin B for invasive aspergillosis.
Karthaus M
N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12494937
[No Abstract] [Full Text] [Related]
18. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Klein KC; Blackwood RA
Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
[TBL] [Abstract][Full Text] [Related]
19. Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.
Graybill JR; Bocanegra R; Gonzalez GM; Najvar LK
J Antimicrob Chemother; 2003 Oct; 52(4):656-62. PubMed ID: 12972452
[TBL] [Abstract][Full Text] [Related]
20. [Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B].
Sato A; Nakatani K; Matsushita Y; Matsuo H; Yamadori H; Kurasawa T; Ikeda Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1141-5. PubMed ID: 8544389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
